Drug companies lose money when manufacturing drugs that cure those suffering from rare diseases because selling a drug to only a few people usually does not recoup manufacturing expenses.Therefore, a company manufacturing any of the drugs that cure those suffering from loxemia, an extremely rare disease, will undoubtedly lose money. Which of the following, if true, most seriously weakens the conclusion above?